Humanwell Healthcare | Briefing, News, Analysis, Research, Data

Humanwell Healthcare

Humanwell Healthcare insists on R&D as the guide

Humanwell Healthcare insists on R&D as the guide, and is at the forefront of R&D investment and new drug R&D progress among domestic pharmaceutical enterprises, and is committed to building a first-class platform for R&D and industrialization of new drugs in China.

Sector

Healthcare

Industry

Biotech/Pharma

Sub-industry

Founded

Mar 30, 1993

HQ location

Hubei, China

Legal name

Humanwell Healthcare (Group) Co., Ltd.

Website

http://www.renfu.com.cn/

renfu.pr@renfu.com.cn

Employees

10001-50000

All
News
Analysis
Research

Briefing Apr 25, 2022 04:05 PM · Technology | Consumer Staples | Healthcare

Nissan announced the progress of assisted driving technology, which can detect the deceleration traffic flow

Briefing Mar 10, 2022 03:59 PM · Technology | Consumer Staples | Healthcare

Meierya: elect Zheng Jiping as chairman and Duan Wenyan as general manager

In-depth

Healthcare

Tsingke Biotechnology: More Opportunities in the International Market of Gene Synthesis

‘Globalization is the only way to the development of the industry. It is more conducive to the rapid progress of the industry for domestic enterprises to compete with well-known overseas enterprises.’

Jan 30, 2023 02:13 PM

Briefing Mar 09, 2022 04:49 PM · Technology | Consumer Staples | Consumer Discretionary

Beijing: it is preliminarily believed that the source of infection of infected person 2 notified on the 8th is from other provinces

Briefing Feb 22, 2022 05:09 PM · Healthcare | Financials | Automotive

Dorui pharmaceutical: clinical approval documents for subsidiaries to purchase new drugs

Research

Healthcare

Digital Therapeutics - Revolution of the healthcare system

Nov 16, 2022 05:19 PM

Research

Healthcare

2022 China AI Health 30 Report

Nov 07, 2022 04:27 PM

Research

Healthcare

2022 China’s Healthcare Industry: An Introductory Handbook

Aug 29, 2022 05:45 PM

Research

Technology, Healthcare, Financials

WIA2020 | 30 Tech Entrepreneurs in China

Apr 22, 2021 03:11 PM

Briefing Feb 14, 2022 05:00 PM · Financials | Automotive | Technology

Optical cable: it is proposed to set up Jiangsu Tong Optoelectronics Technology, which is mainly engaged in raw material trade

Briefing Jan 21, 2022 06:09 PM · Technology | Healthcare

Zhangyu A: Sun Jian, director and general manager, increased 30000 B shares on January 21

Briefing Jan 05, 2022 03:49 PM · Technology | Consumer Staples | Healthcare

China Merchants Steamship: Directors and senior executives plan to reduce their total holdings of no more than 904200 shares

Briefing Jan 04, 2022 04:29 PM · Technology | Consumer Staples | Healthcare

Riyue Co., Ltd. "construction project of finishing production line for key components of large offshore wind power with an annual output of 120000 tons" is planned to be postponed

Healthcare

Biopharma Company IASO Bio Nets Nearly CNY 500 Mn in Series C1

The Chinese leading cell therapy company IASO Bio will soon launch its first commercialized CAR-T product

Jan 18, 2023 10:43 AM

Insight

Healthcare

Opportunities and Challenges Hidden in the CGT Industry in China

CGT (Cell and Gene Therapy) is a sector with high growth potential. CAR-T, as one of the main CGT currently, presents great value for both doctors and patients. This article showcases the industry pain points and opportunities faced in the CAR-T sub-sector.

Jan 17, 2023 05:48 PM

Briefing Dec 06, 2021 03:39 PM · Technology | Healthcare

Hengrui medicine: a number of drugs have been approved to carry out clinical trials

Briefing Dec 03, 2021 03:59 PM · Technology | Consumer Staples | Healthcare

Alex: vometinib mesylate tablets are newly included in the national medical insurance catalogue

Briefing Nov 19, 2021 03:49 PM · Financials | Technology | Consumer Staples

Humanwell pharmaceutical: it is proposed to transfer 2.52% shares of Huatai Insurance with RMB 1.026 billion

Insight

Healthcare

CAR-T Therapy Market Map in China

The market for cell therapy products such as CAR-T is expected to expand rapidly based on increasing investment from the industry and the implementation of advanced technologies.

Jan 16, 2023 02:39 PM

Healthcare

JHM Biopharma Raised Over CNY 100 Mn in Series A+

JHM Biopharma nets another CNY 100 Mn in its Series A round only 3 months after its A1 financing

Jan 16, 2023 09:57 AM

Briefing Oct 18, 2021 01:06 AM · Consumer Staples | Financials

Three quarterly countdown institutions reward the bank sector configuration value

Briefing Oct 08, 2021 03:52 PM · Consumer Discretionary | Healthcare | Industrials

Daqin Railway: in September, the freight volume of Daqin Railway decreased by 1.45% year-on-year

Briefing Sep 27, 2021 03:49 PM · Technology | Healthcare | Financials

West Gate: normal production and stable operation have been restored recently

Briefing Sep 17, 2021 03:50 PM · Technology | Healthcare

Xiangjiang Holdings: it plans to repurchase shares with no more than 145 million yuan

EqualOcean Analysis